CompaniesAlesta Therapeutics
Alesta Therapeutics logo

Alesta Therapeutics

active
Leiden, Netherlands
Founded 2021
Website
About

Oral Small Molecules

Areas of Focus

Categories

Small Molecule Pharmaceutical
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

120

By Phase

PHASE1/PHASE2: 1

By Status

NOT_YET_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
Today
NCT07179640
Hover over trial bars to see details

Recent Trials

NCT07179640Lead Sponsor
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1
PHASE1/PHASE2Not yet recruiting
120 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2027
Locations (1)
Headquarters
Leiden, Netherlands
Map

Loading map...